Work

Efficacy and Safety of Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) With High-Risk (HR) Features: A Subgroup Analysis From the Phase 1/2 MajesTEC-1 Study

Year: 2024

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(24)00951-0

Authors: Luciano J Costa, Nizar J Bahlis, Saad Z Usmani, Niels WCJ van de Donk, Ajay K Nooka, Aurore Perrot, Keqin Qi, Caroline Hodin, Clarissa Uhlar, Athena Zuppa, Katherine Chastain, Margaret Doyle, María-Victoria Mateos

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401879461

FWCI: 0.272

Cites:

Cited by: 1

Related to: 10